Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma.
Yoshitaka NaritaYoshiko OkitaYoshiki ArakawaPublished in: Cancer immunology, immunotherapy : CII (2022)
JapicCTI-183824 (Date of registration: Jan 11, 2018).
Keyphrases